Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
Proc Natl Acad Sci U S A
; 113(44): 12532-12537, 2016 11 01.
Article
in En
| MEDLINE
| ID: mdl-27791128
Full text:
1
Collection:
01-internacional
Health context:
2_ODS3
Database:
MEDLINE
Main subject:
Peptides
/
Vaccination
/
Colonic Neoplasms
/
Vascular Endothelial Growth Factor A
/
Bevacizumab
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Proc Natl Acad Sci U S A
Year:
2016
Document type:
Article